We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
-10.43%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$410M
AUM Growth
-$56.7M
Cap. Flow
-$2.58M
Cap. Flow %
-0.63%
Top 10 Hldgs %
34.04%
Holding
74
New
3
Increased
25
Reduced
37
Closed
3

Top Buys

Rank Stock Value
1
CACC icon
Credit Acceptance
CACC
+$1.3M
2
UNH icon
UnitedHealth
UNH
+$1.1M
3
EXPD icon
Expeditors International
EXPD
+$460K
4
MRSH
Marsh
MRSH
+$438K
5
GILD icon
Gilead Sciences
GILD
+$352K

Top Sells

Rank Stock Value
1
DLX icon
Deluxe
DLX
+$3.28M
2
MA icon
Mastercard
MA
+$483K
3
EV
Eaton Vance Corp.
EV
+$405K
4
ROL icon
Rollins
ROL
+$333K
5
NVO
Novo Nordisk
NVO
+$329K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.03%
2 Industrials 18.87%
3 Technology 17.6%
4 Financials 13.25%
5 Consumer Staples 12.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AME icon
26
Ametek
AME
$53.9B
$7.29M 1.78%
107,616
-237
-0.2% -$17K
NVO
27
Novo Nordisk
NVO
$219B
$7.24M 1.76%
314,178
-14,816
-5% -$329K
MRSH
28
Marsh
MRSH
$87.7B
$7.2M 1.76%
90,342
+5,257
+6% +$438K
DEO icon
29
Diageo
DEO
$47.2B
$6.89M 1.68%
48,564
+1,520
+3% +$214K
DLTR icon
30
Dollar Tree
DLTR
$24.3B
$6.4M 1.56%
70,878
-1,824
-3% -$154K
EV
31
DELISTED
Eaton Vance Corp.
EV
$6.09M 1.48%
173,036
-9,595
-5% -$405K
CNI icon
32
Canadian National Railway
CNI
$76.9B
$6.04M 1.47%
81,534
-100
-0.1% -$8.29K
ABBV icon
33
AbbVie
ABBV
$448B
$5.79M 1.41%
62,793
+187
+0.3% +$16.4K
SYK icon
34
Stryker
SYK
$122B
$5.61M 1.37%
35,817
+110
+0.3% +$18.4K
EXPD icon
35
Expeditors International
EXPD
$23.2B
$5.57M 1.36%
81,798
+6,544
+9% +$460K
PII icon
36
Polaris
PII
$4.14B
$5.08M 1.24%
66,302
-406
-0.6% -$36.5K
HSIC icon
37
Henry Schein
HSIC
$9.82B
$4.5M 1.1%
73,059
+1,891
+3% +$125K
SLGN icon
38
Silgan Holdings
SLGN
$4.87B
$4.4M 1.07%
186,253
-4,390
-2% -$110K
LLY icon
39
Eli Lilly
LLY
$1.02T
$3.27M 0.8%
28,219
– –
RTN
40
DELISTED
Raytheon Company
RTN
$3.02M 0.74%
19,702
+536
+3% +$96K
LEA icon
41
Lear
LEA
$7.02B
$2.94M 0.72%
23,960
-189
-0.8% -$25.3K
K
42
DELISTED
Kellanova
K
$2.86M 0.7%
53,388
-819
-2% -$49.4K
UNH icon
43
UnitedHealth
UNH
$383B
$2.72M 0.66%
10,911
+4,163
+62% +$1.1M
DLX icon
44
Deluxe
DLX
$1.19B
$2.56M 0.62%
66,556
-68,846
-51% -$3.28M
SHW icon
45
Sherwin-Williams
SHW
$79.8B
$2.44M 0.6%
18,630
+735
+4% +$99.2K
KMB icon
46
Kimberly-Clark
KMB
$36B
$2.44M 0.59%
21,420
– –
FDS icon
47
Factset
FDS
$9.1B
$2.44M 0.59%
12,180
+285
+2% +$62.8K
RHI icon
48
Robert Half
RHI
$4.28B
$2.39M 0.58%
41,859
+220
+0.5% +$13.5K
ALK icon
49
Alaska Air
ALK
$5.13B
$1.89M 0.46%
31,059
-2,768
-8% -$179K
TSM icon
50
TSMC
TSM
$2.09T
$1.63M 0.4%
44,254
-35
-0.1% -$1.33K
1
2
3

Similar funds

AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
FCM
Fourpath Capital Management Oklahoma City, Oklahoma $697M AUM 29.98% 1-Year Est. Return
GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
AWC
Abundance Wealth Counselors State College, Pennsylvania $697M AUM 23.83% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $696M AUM 17.73% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JLB & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, JLB & Associates held 74 positions worth $410M, down 12% from $467M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

JLB & Associates's Q4 2018 filing shows 3 new, 25 increased, 37 reduced and 3 closed positions. Its largest new stake was Credit Acceptance: 3,239 shares worth $1.24M. The largest sale was Deluxe, an estimated $3.28M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 20% a quarter earlier, followed by Industrials and Technology.

  • JLB & Associates's largest Q4 2018 buy was Credit Acceptance: 3,239 shares worth $1.24M.
  • JLB & Associates added most to UnitedHealth in Q4 2018, an estimated $1.1M increase.
  • JLB & Associates's biggest Q4 2018 reduction was Deluxe, cutting an estimated $3.28M.
  • JLB & Associates fully exited Northrop Grumman in Q4 2018, selling an estimated $271K.
  • JLB & Associates's ten largest holdings make up 34% of its $410M portfolio in Q4 2018.
  • JLB & Associates opened 3 new positions and closed 3 in Q4 2018.
  • JLB & Associates's portfolio value fell 12% quarter-over-quarter to $410M.

Based on JLB & Associates's 13F filing for Q4 2018, filed 11 Jan 2019.